What one share of Propanc Biopharma holds
Propanc Biopharma’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$17.62 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$5.06 |
| Cash and investments | $0.25 |
| Debt | $0.02 |
| Book value | $2.84 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$274.24 | $0.14 | −$98.25 | — | −$111.09 |
| 2021 | — | −$19.93 | — | — | — | — |
| 2023 | — | −$44.96 | — | — | — | — |
| 2025 | — | −$371.22 | — | — | — | — |
| 2026 | — | −$17.62 | $0.00 | −$5.06 | — | $2.84 |
Common questions about Propanc Biopharma
How much does one share of Propanc Biopharma earn?
Over its latest fiscal year, Propanc Biopharma lost $17.62 for each share.
Does Propanc Biopharma pay a dividend?
Propanc Biopharma didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Propanc Biopharma’s book value per share?
Propanc Biopharma’s book value is $2.84 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Propanc Biopharma have?
Each share of Propanc Biopharma has $0.25 of cash and investments and $0.02 of debt, as of June 30, 2026.
What is Propanc Biopharma’s free cash flow per share?
−$5.06 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Propanc Biopharma bought back shares?
Propanc Biopharma’s share count rose about 5252% from 2019 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.